» Authors » Katrin Petermann

Katrin Petermann

Explore the profile of Katrin Petermann including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 16
Citations 145
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Colombo A, Bernasconi E, Alva L, Sousa M, Debove I, Nowacki A, et al.
Mov Disord . 2025 Mar; PMID: 40079832
Background: Novel commercial brain-sense neurostimulators enable us to contextualize brain activity with symptom and medication states in real-life ambulatory settings in Parkinson's disease (PD). Although various candidate biomarkers have been...
2.
Bruhin L, Single M, Naef A, Petermann K, Sousa M, Castelli M, et al.
BMC Neurol . 2025 Jan; 25(1):25. PMID: 39825282
Background: Effects of subthalamic nucleus deep brain stimulation (STN-DBS) on neuropsychiatric symptoms of Parkinson's disease (PD) remain debated. Sensor technology might help to objectively assess behavioural changes after STN-DBS. Case...
3.
Bernasconi E, Amstutz D, Averna A, Fischer P, Sousa M, Debove I, et al.
NPJ Parkinsons Dis . 2025 Jan; 11(1):4. PMID: 39753562
Sensing-based deep brain stimulation should optimally consider both the motor and neuropsychiatric domain to maximize quality of life of Parkinson's disease (PD) patients. Here we characterize the neurophysiological properties of...
4.
Amstutz D, Petermann K, Sousa M, Debove I, Maradan-Gachet M, Bruhin L, et al.
Mov Disord Clin Pract . 2025 Jan; PMID: 39749399
Background: Impulse control disorders (ICD) are common side effects of dopaminergic treatment in Parkinson's disease (PD). Whereas some studies show a reduction in ICD after subthalamic nucleus deep brain stimulation...
5.
Murcia Carretero S, Petermann K, Debove I, Amstutz D, Sousa M, Waskonig J, et al.
Mov Disord Clin Pract . 2024 Sep; 11(11):1379-1387. PMID: 39225548
Background: Deep brain stimulation (DBS) of the subthalamic nucleus (STN) and globus pallidus internus (GPi) is an accepted therapy for Parkinson's disease (PD) with disabling motor complications. For elderly patients...
6.
Magalhaes A, Amstutz D, Petermann K, Debove I, Sousa M, Maradan-Gachet M, et al.
BMJ Neurol Open . 2024 Jan; 6(1):e000524. PMID: 38196982
Background: Subthalamic nucleus deep brain stimulation (STN-DBS) is a well-established treatment for motor complications in Parkinson's disease (PD). However, its effects on neuropsychiatric symptoms remain disputed. The aim of this...
7.
Leserri S, Segura-Amil A, Nowacki A, Debove I, Petermann K, Schappi L, et al.
Eur Arch Psychiatry Clin Neurosci . 2023 Sep; 274(3):685-696. PMID: 37668723
Treatment-resistant depression is a severe form of major depressive disorder and deep brain stimulation is currently an investigational treatment. The stimulation's therapeutic effect may be explained through the functional and...
8.
Segura-Amil A, Nowacki A, Debove I, Petermann K, Tinkhauser G, Krack P, et al.
Hum Brain Mapp . 2023 Jun; 44(12):4439-4451. PMID: 37318767
Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is an effective treatment for advanced Parkinson's disease. Stimulation of the hyperdirect pathway (HDP) may mediate the beneficial effects, whereas stimulation...
9.
Debove I, Petermann K, Nowacki A, Nguyen T, Tinkhauser G, Michelis J, et al.
Mov Disord Clin Pract . 2023 Mar; 10(3):434-439. PMID: 36949800
Background: Directional deep brain stimulation (DBS) allows for steering of the stimulation field, but extensive and time-consuming testing of all segmented contacts is necessary to identify the possible benefit of...
10.
Herzog L, Kook L, Gotschi A, Petermann K, Hansel M, Hamann J, et al.
Biom J . 2022 Dec; 65(6):e2100379. PMID: 36494091
In many medical applications, interpretable models with high prediction performance are sought. Often, those models are required to handle semistructured data like tabular and image data. We show how to...